Chronic, low-level exposure to the cholinesterase inhibitor DFP. I. Time course of neurochemical changes in the rat pontomesencephalic tegmentum

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 1, 1999, Pages 95-103

  Deurveilher, Samuel ^a   Delamanche, Iroudayanadin S ^b   Hars, Bernard ^a   Breton, Patrick ^b   Hennevin, Elizabeth ^a  

^a CNRS   (France)

^b CENTRE D ETUDES DU BOUCHET   (France)

Author keywords

Cholinesterase assay; Chronic low level exposure; DFP; Irreversible cholinesterase inhibitor; Plasma; Pontomesencephalic tegmentum; Quantitative 3H QNB autoradiography; Quantitative cholinesterase histochemistry; Rat; Striatum

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DYFLOS;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN STEM; CONTROLLED STUDY; HISTOCHEMISTRY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; IMMUNOHISTOCHEMISTRY; ISOFLUROPHATE; MALE; MUSCARINIC ANTAGONISTS; NEOSTRIATUM; PONS; QUINUCLIDINYL BENZILATE; RATS; RATS, WISTAR; TEGMENTUM MESENCEPHALI;

EID: 0032885116     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00069-6     Document Type: Article

References (46)

1. Abdallah E.A.M., El-Fakahany E.E. Lack of desensitization of muscarinic receptor-mediated second messager signals in rat brain upon acute and chronic inhibition of acetylcholinesterase. J. Biochem. Toxicol. 6:1991;261-268.
2. Baghdoyan H.A. Location and quantification of muscarinic receptor subtypes in rat pons. Implications for REM sleep generation Am. J. Physiol. 273:1997;R896-R904.
3. Bushnell P.J., Padilla S.S., Ward T., Pope C.N., Olszyk V.B. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J. Pharmacol. Exp. Ther. 256:1991;741-750.
4. Chaudhuri J., Chakraborti T.K., Chanda S., Pope C.N. Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos. J. Biochem. Toxicol. 8:1993;207-216.
5. Chiappa S., Padilla S., Koenigsberger C., Moser V., Brimijoin S. Slow accumulation of acetylcholinesterase in rat brain during enzyme inhibition by repeated dosing with chlorpyrifos. Biochem. Pharmacol. 49:1995;955-963.
6. Chippendale T.J., Zawolkow G.A., Russell R.W., Overstreet D.H. Tolerance to low acetylcholinesterase levels. Modification of behavior without acute behavioral change Psychopharmacologia. 26:1972;127-139.
7. Churchill L., Pazdernik T.L., Samson F., Nelson S.R. Topographical distribution of down-regulated muscarinic receptors in rat brains after repeated exposure to diisopropyl phosphorofluoridate. Neuroscience. 11:1984;463-472.
8. 3H]quinuclidinyl benzilate binding in the striatum of rats following chronic cholinesterase inhibition with diisopropylfluorophosphate. Mol. Pharmacol. 17:1980;24-30.
9. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
10. Fitzgerald B.B., Costa L.G. Modulation of M1 and M2 muscarinic receptor subtypes following repeated organophosphate exposure in rats. Toxicol. Appl. Pharmacol. 117:1992;122-125.
11. Fitzgerald B.B., Costa L.G. Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and brain areas following repeated organophosphate exposure in rats. Fundam. Appl. Toxicol. 20:1993;210-216.
12. Gazit H., Silman I., Dudai Y. Administration of an organophosphate causes a decrease in muscarinic receptor levels in rat brain. Brain Res. 174:1979;351-356.
13. Gearhart J.M., Jepson G.W., Clewell H.J., Andersen M.E., Conolly R.B. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate. Toxicol. Appl. Pharmacol. 196:1990;295-310.
14. Glow P.H., Rose S., Richardson A. The effect of acute and chronic treatment with diisopropyl fluorophosphate on cholinesterase activities on some tissues of the rat. Aust. J. Exp. Biol. Med. Sci. 44:1966;73-86.
15. Hammond P.I., Jelacic T., Padilla S., Brimijoin S. Quantitative, video-based histochemistry to measure regional effects of anticholinesterase pesticides in rat brain. Anal. Biochem. 241:1996;82-92.
16. Howerton T.C., Murphy M.R., Miller S.A., Hartgraves S.L. Differential sensitivity of CNS regions to acetylcholinesterase inhibition following chronic low-dose soman treatment in the rat. Psychopharmacology (Berlin). 105:1991;400-406.
17. Koelle G.B., Friedenwald J.S. A histochemical method for localizing cholinesterase activity. Proc. Soc. Exp. Biol. 70:1949;617-622.
18. Kozar M.D., Overstreet D.H., Chippendale T.C., Russell R.W. Changes of acetylcholinesterase activity in three major brain areas and related changes in behaviour following acute treatment with diisopropyl fluorophosphate. Neuropharmacology. 15:1976;291-298.
19. Lemercier G., Carpentier P., Sentenac-Roumanou H., Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorous compound. Acta Neuropathol. 61:1983;123-129.
20. Lim D.K., Hoskins B., Ho I.K. Correlation of muscarinic receptor density and acetylcholinesterase activity in repeated DFP-treated rats after the termination of DFP administration. Eur. J. Pharmacol. 123:1986;223-228.
21. Lim D.K., Hoskins B., Ho I.K. Effects of diisopropylfluorophosphate on brain acetylcholinesterase, butyrylcholinesterase, and neurotoxic esterase in rats. Biomed. Environ. Sci. 2:1989;295-304.
22. Llorens J., Crofton K.M., Tilson H.A., Ali S.F., Mundy W.R. Characterization of disulfoton-induced behavioral and neurochemical effects following repeated exposure. Fundam. Appl. Toxicol. 20:1993;163-169.
23. 3H]diisopropylfluorophosphate in mice. Toxicol. Appl. Pharmacol. 77:1985;275-284.
24. Massoulié J., Pezzementi L., Bon S., Krejci E., Vallette F.M. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41:1993;31-91.
25. McCarley R.W., Greene R.W., Rainnie D., Portas C.M. Brainstem neuromodulation and REM sleep. Semin. Neurosci. 7:1995;341-354.
26. Meneguz A., Bisso G.M., Michalek H. Regional differences in brain-soluble acetylcholinesterase and its molecular forms after acute poisoning by isoflurophate in rats. Clin. Toxicol. 18:1981;1443-1451.
27. Michalek H., Meneguz A., Bisso G.M. Mechanisms of recovery of brain acetylcholinesterase in rats during chronic intoxication with isofluorophate. Arch. Toxicol. Suppl. 5:1982;116-119.
28. Mundy W.R., Ward T.R., Dulchinos V.F., Tilson H.A. Effect of repeated organophosphate administration on carbachol-stimulated phosphoinositide hydrolysis in the rat brain. Pharmacol. Biochem. Behav. 45:1993;309-314.
29. Overstreet D.H., Russell R.W., Helps S.C., Runge P., Prescott A.M. Sex differences following pharmacological manipulation of the cholinergic system by DFP and pilocarpine. Psychopharmacology (Berlin). 61:1979;49-58.
30. Padilla S., Wilson V.Z., Bushnell P.J. Studies on the correlation between blood cholinesterase inhibition and "target tissue" inhibition in pesticide-treated rats. Toxicology. 92:1994;11-25.
31. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, San Diego, CA.
32. Pintor A., Fortuna S., De Angelis S., Michalek H. Impaired recovery of brain muscarinic receptor sites following an adaptive down-regulation induced by repeated administration of diisopropyl fluorophosphate in aged rats. Life Sci. 46:1990;1027-1036.
33. Prendergast M.A., Terry A.V., Buccafusco J.J. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning. Psychopharmacology (Berlin). 129:1997;183-191.
34. 2-like receptor sub-type. Neuroscience. 29:1989;271-289.
35. Russell R.W., Overstreet D.H. Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds. Prog. Neurobiol. 28:1987;97-129.
36. Santhoshkumar P., Karanth S., Shivanandappa T. Neurotoxicity and pattern of acetylcholinesterase inhibition in the brain regions of rat by bromophos and ethylbromophos. Fundam. Appl. Toxicol. 32:1996;23-30.
37. Schwab B.W., Hand H., Costa L.G., Murphy S.D. Reduced muscarinic receptor binding in tissues of rats tolerant to the insecticide disulfoton. Neurotoxicology. 2:1981;635-647.
38. Semba K. The mesopontine cholinergic system. A dual role in REM sleep and wakefulness Lydic R., Baghdoyan H.A. Handbook of behavioural state control. Cellular and molecular mechanisms:1999;161-180 CRC Press, Boca Raton, FL.
39. Sivam S.P., Hoskins B., Ho I.K. An assessment of comparative acute toxicity of diisopropyl-fluorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats. Fundam. Appl. Toxicol. 4:1984;531-538.
40. Sivam S.P., Norris J.C., Lim D.K., Hoskins B., Ho I.K. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum. J. Neurochem. 40:1983;1414-1422.
41. Steriade M., McCarley R.W. Brainstem control of wakefulness and sleep. 1990;Plenum Press, New York.
42. Traina M.E., Serpietri L.A. Changes in the levels and forms of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate intoxication. Biochem. Pharmacol. 33:1984;645-653.
43. Van de Kamp J.L., Collins A.C. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors. Pharmacol. Biochem. Behav. 42:1992;131-141.
44. Van Dongen C.J., Wolthuis O.L. On the development of behavioral tolerance to organophosphates I. Behavioral and biochemical aspects Pharmacol. Biochem. Behav. 34:1989;473-481.
45. Yamada S., Isogai M., Okudaira H., Hayashi E. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration. antagonism by physostigmine and atropine J. Pharmacol. Exp. Ther. 226:1983;519-525.
46. Yamada S., Isogai M., Okudaira H., Hayashi E. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine. Brain Res. 268:1983;315-320.